Active Pharmaceutical Ingredients (API) Market Segmentation by Type (Generic, and Innovative); by Synthesis Type (Synthetic, and Biotech); by Therapeutic Application (Communicable Diseases, Oncology, Diabetes, Cardiovascular Disease, Musculoskeletal Disorders, Respiratory Diseases, and Other Therapeutic Applications); by Business Mode (Captive, and Merchant)-Global Demand Analysis & Opportunity Outlook 2020-2030

Global Active Pharmaceutical Ingredients (API) Market Highlights Over 2020 - 2030

The global active pharmaceutical ingredients (API) market is estimated to garner a revenue of USD 331.37 Billion by the end of 2030, by growing at a CAGR of 6.08% over the forecast period, i.e., 2021 – 2030. Moreover, the market generated a revenue of USD 185.23 Billion in the year 2020. The growth of the market can be attributed to the growing concern for the rising prevalence of chronic diseases worldwide, which is driving the need to develop advanced medications to treat these diseases. According to the statistics by the World Health Organization (WHO), in the year 2019, around 17.9 Million people died from cardiovascular diseases (CVDs). Additionally, in the other statistics by the WHO, in the year 2019, around 1.5 Million deaths were caused due to diabetes, while, in the year 2020, cancer accounted for around 10 Million deaths. To treat these chronic diseases specialized drugs are required, which is driving the need for APIs amongst the pharmaceutical drug manufacturers.

CLICK TO DOWNLOAD SAMPLE REPORT

The growth of the market can also be attributed to the increasing demand for generic drugs, backed by the increasing number of generic drug approvals worldwide by governmental authorities. Besides this, the increasing advancements in healthcare, backed by the rising healthcare expenditure, is also expected to create numerous opportunities for the growth of the market. Additionally, the rising focus on the development of precision medicines, along with the rising demand for biosimilar drugs and the emergence of highly potency APIs (HPAPIs) are some of the opportunities anticipated to boost the market growth in the years to come.

Global Active Pharmaceutical Ingredients (API) Market Regional Synopsis

Regionally, the global active pharmaceutical ingredients (API) market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America is anticipated to garner the largest revenue of USD 127.61 Billion by the end of 2030, up from a revenue of USD 71.70 Billion in the year 2020. The growth of the market in the region can be attributed to the presence of a strong healthcare network, along with the rising healthcare expenditure. Moreover, increasing prevalence of chronic diseases in the region, especially in the United States, which according to the statistics by the Centers for Disease Control and Prevention (CDC) recorded having a chronic disease among 6 adults out of 10 adults, and two or more chronic diseases among 4 adults out of 10 adults. The market in the region can further be segmented by country into the United States and Canada. Out of these, the market in the United States is expected to garner the largest revenue by the end of 2030 and also grow with the highest CAGR of 6.03% during the forecast period. On the other hand, the market in the Asia Pacific is anticipated to garner the second-largest revenue of USD 104.98 Billion by the end of 2030. The market in the region is further segmented by country into Japan, Australia, Singapore, South Korea, India, China, and the Rest of Asia Pacific. Out of these, the market in China is projected to generate the largest revenue of USD 36.90 Billion by the end of 2030.

Growth Drivers and Challenges Impacting the Growth of the Global Active Pharmaceutical Ingredients (API) Market

Growth Drivers

• Rising Prevalence of Chronic and Infectious Diseases Worldwide

• Increasing Demand for Generic Drugs

Challenges

• High Cost of Manufacturing of APIs

Global Active Pharmaceutical Ingredients (API) Market Segmentation Synopsis

The global active pharmaceutical ingredients (API) market is segmented by type into generic, and innovative, out of which, the generic segment is projected to grow with the highest CAGR of 6.28% during the forecast period. Further, by synthesis type, the market is segmented into synthetic and biotech, out of which, the synthetic segment is projected to garner the largest revenue by the end of 2030. By therapeutic application, the market is segmented into communicable disease, oncology, diabetes, cardiovascular disease, musculoskeletal disorders, respiratory disorders, and other therapeutic applications. Out of these, the cardiovascular disease segment is anticipated to garner the largest revenue of USD 68.81 Billion by the end of 2030, up from a revenue of USD 39.50 Billion in the year 2020. Additionally, by business mode, the market is segmented into captive and merchant, out of which, the merchant segment is expected to grow with the highest CAGR of 6.22% during the forecast period.

Key Companies Dominating the Market

Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global active pharmaceutical ingredients (API) market that are included in our report are Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Sanofi-aventis Groupe, Boehringer Ingelheim International GmbH, Aurobindo Pharma, Dr. Reddy’s Laboratories Ltd., API Corporation, Bristol-Myers Squibb Company, KATSURA CHEMICAL CO., LTD., and others.

Latest Developments in the Global Active Pharmaceutical Ingredients (API) Market:

• May 18^th, 2021: Novartis AG announced that its Sandoz division would expand the production capabilities in Kundl, Austria and in Palafolls, Spain. This step of the company is aligned with its plans which was proposed in July 2020, in a collaboration with the Austrian government, that focuses on investing more than USD 118 Million in the first step, for introducing a new manufacturing technology for the production of an API, oral amoxicillin, for its leading penicillin product.

• June 16^th, 2017: Bristol-Myers Squibb Company announced that it has signed a definitive purchase agreement with SK Biotek Co., Ltd., where the latter would purchase the small molecule active pharmaceutical ingredient (API) manufacturing facility of Bristol-Myers Squibb, located in Swords, Ireland.

Key Reasons to Buy Our Report

• The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.

• It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.

• The report includes detailed company profiles of the major players dominating the market.

• We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.

• We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.

Geography Analysis:

The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

• North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
• Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
• Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys  & Opportunity Outlook
• Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
• Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook

.